77Approvals for nominated Schedule 4 substances not required in certain circumstances—the Act, s 69(1)

77 Approvals for nominated Schedule 4 substances not required in certain circumstances—the Act, s 69(1)

77 Approvals for nominated Schedule 4 substances not required in certain circumstances—the Act, s 69(1)

(1) This section sets out the circumstances in which an authorised practitioner does not require an approval under section 76 to supply, administer or issue a prescription for a nominated Schedule 4 substance.

Note—

The Act, section 69(2) and (3) set out other circumstances in which an approval is not required.

(2) An authorised practitioner does not require an approval for a nominated Schedule 4 substance for the treatment of a patient of—

(a) a public health entity or private health facility, or

(b) a correctional centre for the purposes of continuing the treatment the patient was receiving immediately before the patient became an inmate.

(3) An authorised practitioner (the replacement practitioner) does not require an approval for a nominated Schedule 4 substance if—

(a) the replacement practitioner carries out the activity on behalf of another authorised practitioner who holds an approval for the activity and is temporarily unavailable (the original practitioner), and

(b) the activity is required for the continued treatment of a patient of the original practitioner, and

(c) the replacement practitioner—

(i) practises at the same practice or premises as the original practitioner, or

(ii) is nominated by the original practitioner to carry out the activity.

(4) A veterinary practitioner does not require an approval for a nominated Schedule 4 substance.

(5) A medical practitioner with a specialist registration specified in Column 1 of the table to this subsection does not require an approval for a nominated Schedule 4 substance specified opposite in Column 2.

| Column 1 | Column 2 | | Specialist registration | Nominated Schedule 4 substance | | Dermatology | AcitretinAlefaceptBexaroteneEtretinateIsotretinoin for oral useThalidomide | | Obstetrics and gynaecology | ClomifeneCorifollitropin alfaCyclofenilDinoprostDinoprostoneFollitropin alfaFollitropin betaFollitropin deltaLuteinising hormoneUrofollitropin | | Physician | AcitretinAmbrisentanBexaroteneBosentanClomifeneCyclofenilEnzalutamideEtretinateFollitropin betaIsotretinoin for oral useLenalidomideLuteinising hormoneMacitentanPomalidomideRiociguatSitaxentanTeriparatideThalidomideTretinoin for oral use |